Modern Methods of Producing a Vaccine against Brucellosis in Small Ruminants and the Examination of its Immunogenicity in Laboratory Animals
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 69
Abstract
The purpose of the study is to experimentally substantiate the immunobiological properties, protective efficacy, duration of action, and safety of a new subunit vaccine against brucellosis in small ruminants. The vaccine was developed based on a recombinant outer membrane protein of Brucella melitensis, and its efficacy was evaluated using a BALB/c mouse model. The recombinant method provides the highest yield of antigenic protein (145±18 milligrams per litre), preparation stability for up to 12 months, and a production time of 14±3 days. Expression of the target gene is confirmed using quantitative reverse transcription polymerase chain reaction, showing a 12.6-fold increase in messenger RNA levels. Specificity of the obtained antigen is demonstrated using immunoblotting (intensity of 1680±140 arbitrary units compared with 280±60 units in the control) and mass spectrometry with 78.3 per cent coverage of the amino acid sequence. Immunisation induces an increase in IgG (up to 1:5120), a rise in the proportion of helper-type T-lymphocytes to 32 per cent, and an interferon-gamma (IFN-γ) concentration of 450 picograms per millilitre. Following infection, survival in the experimental group is 95 per cent, whereas the group receiving the standard live vaccine Rev.1 shows 75 per cent survival; histological changes in liver and spleen tissues are minimal. At 180 days post-immunisation, the IgG remained at 1:1920, IFN-γ concentration measured 220 picograms per millilitre, and the protective effect was maintained in 90 per cent of vaccinated animals.This publication has 29 references indexed in Scilit:
- Opportunities and challenges in harnessing the immunomodulatory potential of bacterial extracellular vesicles as vaccine candidatesDiscover Immunity, 2025
- Naturally Occurring Isorhamnetin Glycosides as Potential Agents Against Influenza Viruses: Antiviral and Molecular Docking StudiesACS Omega, 2023
- A survey of the parasites of Ural saiga antelopes and Turkmenian kulans of KazakhstanInternational Journal for Parasitology: Parasites and Wildlife, 2023
- T-B cell epitope peptides induce protective immunity against Mycoplasma pneumoniae respiratory tract infection in BALB/c miceImmunobiology, 2021
- High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella speciesComparative Immunology, Microbiology and Infectious Diseases, 2020
- Phenotypic and genotypic characteristics of Brucella isolates from the Republic of KazakhstanTropical Animal Health and Production, 2019
- The identification of wadB, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of Brucella abortusMicrobial Pathogenesis, 2014
- Characterization of pigeon paramyxoviruses (Newcastle disease virus) isolated in Kazakhstan in 2005Virologica Sinica, 2012
- Rough vaccines in animal brucellosis: Structural and genetic basis and present statusVeterinary Research, 2004
- Brucellosis vaccines: past, present and futureVeterinary Microbiology, 2002